These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 7803250)

  • 61. Search for mutations in the genes for coagulation factors V and VIII with a possible predisposition to activated protein C resistance.
    Bokarewa MI; Falk G; Bremme K; Blombäck M; Wiman B
    Eur J Clin Invest; 1997 Apr; 27(4):340-5. PubMed ID: 9134384
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Biochemical prototype for familial thrombosis. A study combining a functional protein C mutation and factor V Leiden.
    Kalafatis M; Lu D; Bertina RM; Long GL; Mann KG
    Arterioscler Thromb Vasc Biol; 1995 Dec; 15(12):2181-7. PubMed ID: 7489240
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Diagnosis strategies in activated protein C resistance: is genotyping still necessary?
    Biron C; Lamarti H; Schved JF; Jeanjean P; Masmejean C; Claustres M; Aguilar-Martinez P
    Clin Lab Haematol; 1997 Mar; 19(1):67-71. PubMed ID: 9146951
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Female gender and resistance to activated protein C (FV:Q506) as potential risk factors for thrombosis after elective hip arthroplasty.
    Svensson PJ; Benoni G; Fredin H; Björgell O; Nilsson P; Hedlund U; Nylander G; Bergqvist D; Dahlbäck B
    Thromb Haemost; 1997 Sep; 78(3):993-6. PubMed ID: 9308742
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Mutation in the gene coding for coagulation factor V and resistance to activated protein C: detection of the genetic mutation by oligonucleotide ligation assay using a semi-automated system.
    Zotz RB; Maruhn-Debowski B; Scharf RE
    Thromb Haemost; 1996 Jul; 76(1):53-5. PubMed ID: 8819251
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Activated protein C resistance and venous thrombophilia: molecular genetic prevalence study in the German population].
    Ehrenforth S; Klinke S; von Depka Prondzinski M; Kreuz W; Ganser A; Scharrer I
    Dtsch Med Wochenschr; 1999 Jun; 124(25-26):783-7. PubMed ID: 10414227
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Association of elevated levels of prothrombin fragment 1+2 and Arg506 to Gln mutation in patients with a history of ischemic stroke.
    De Lucia D; Papa ML; Ammendola F; Pezzella S; Del Giudice V; Marotta R; Renis V; Di Mauro C; Maisto G; Masi S; Nina P; Franco A; Schisano G
    J Neurosurg Sci; 1999 Mar; 43(1):45-50; discussion 50-1. PubMed ID: 10494665
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Activated protein C resistance caused by a common factor V mutation has a single origin.
    Zöller B; Hillarp A; Dahlbäck B
    Thromb Res; 1997 Feb; 85(3):237-43. PubMed ID: 9058498
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Co-segregation of thrombosis with the factor V Q506 mutation in an extended family with resistance to activated protein C.
    Beufé S; Borg JY; Vasse M; Charbonnier F; Moreau V; Monconduit M; Frebourg T
    Br J Haematol; 1995 Mar; 89(3):659-62. PubMed ID: 7734374
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Familial thrombophilia: clinical and molecular analysis of Swedish families with inherited resistance to activated protein C or protein S deficiency.
    Zöller B
    Scand J Clin Lab Invest Suppl; 1996; 226():19-46. PubMed ID: 8981666
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Brief report: variability of thrombosis among homozygous siblings with resistance to activated protein C due to an Arg-->Gln mutation in the gene for factor V.
    Greengard JS; Eichinger S; Griffin JH; Bauer KA
    N Engl J Med; 1994 Dec; 331(23):1559-62. PubMed ID: 7969326
    [No Abstract]   [Full Text] [Related]  

  • 72. Evaluation of original and modified APC-resistance tests in unselected outpatients with clinically suspected thrombosis and in healthy controls.
    Svensson PJ; Zöller B; Dahlbäck B
    Thromb Haemost; 1997 Feb; 77(2):332-5. PubMed ID: 9157592
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The R306G and R506Q mutations in coagulation Factor V reveals additional cleavage sites for Activated Protein C in the R313-R321 region and at R505.
    Dirven RJ; Vos HL; Bertina RM
    Thromb Res; 2010 May; 125(5):444-50. PubMed ID: 20051284
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Resistance to activated protein C and a novel factor V gene mutation.
    Voelkerding KV
    Clin Lab Med; 1996 Mar; 16(1):169-86. PubMed ID: 8867589
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Three novel variants in the coagulation factor V gene associated with deep venous thrombosis in Chilean patients with Amerindian ethnic background.
    Guzmán N; Larama G; Ávila A; Salazar LA
    Clin Chim Acta; 2015 Apr; 444():24-8. PubMed ID: 25668227
    [TBL] [Abstract][Full Text] [Related]  

  • 76. High prevalence of the FVR506Q mutation causing APC resistance in a region of southern Sweden with a high incidence of venous thrombosis.
    Zöller B; Norlund L; Leksell H; Nilsson JE; von Schenck H; Rosén U; Jepsson JO; Dahlbäck B
    Thromb Res; 1996 Sep; 83(6):475-7. PubMed ID: 8885142
    [No Abstract]   [Full Text] [Related]  

  • 77. A chromogenic assay for activated protein C resistance.
    Váradi K; Moritz B; Lang H; Bauer K; Preston E; Peake I; Rivard GE; Keil B; Schwarz HP
    Br J Haematol; 1995 Aug; 90(4):884-91. PubMed ID: 7669667
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Resistance to activated protein C as an additional genetic risk factor in hereditary deficiency of protein S.
    Zöller B; Berntsdotter A; García de Frutos P; Dahlbäck B
    Blood; 1995 Jun; 85(12):3518-23. PubMed ID: 7780138
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Low prevalence of activated protein C resistance and coagulation factor V Arg506 to Gln mutation among Korean patients with deep vein thrombosis.
    Kim TW; Kim WK; Lee JH; Kim SB; Kim SW; Suh C; Lee KH; Lee JS; Seo EJ; Chi HS; Kim SH
    J Korean Med Sci; 1998 Dec; 13(6):587-90. PubMed ID: 9886165
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Factor V gene mutation is a risk factor for cerebral venous thrombosis.
    Martinelli I; Landi G; Merati G; Cella R; Tosetto A; Mannucci PM
    Thromb Haemost; 1996 Mar; 75(3):393-4. PubMed ID: 8701395
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.